Characterization of the complete chloroplast genome of a medicinal species Euodia ruticarpa in China (Rutaceae)

Hao Liu; Jian Jin; Rongrong Zhou; Can Zhong; Jing Xie; Weiliang Zhou; Shuihan Zhang

doi:10.1080/23802359.2020.1829125

Characterization of the complete chloroplast genome of a medicinal species Euodia ruticarpa in China (Rutaceae)

Mitochondrial DNA B Resour. 2020 Oct 12;5(3):3558-3560. doi: 10.1080/23802359.2020.1829125.

Authors

Hao Liu¹, Jian Jin^{1

2}, Rongrong Zhou³, Can Zhong¹, Jing Xie¹, Weiliang Zhou⁴, Shuihan Zhang^{1

2}

Affiliations

¹ Hunan Academy of Chinese Medicine, Institute of Chinese Materia Medica, Changsha, PR China.
² Hunan University of Chinese Medicine, Changsha, PR China.
³ Chinese Academy of Chinese Medical Sciences, National Resource Center for Chinese Meteria Medica, Beijing, PR China.
⁴ Hunan Shenzhou Chinese Medicine Inc, Cili, China.

Abstract

Euodia ruticarpa is a medicinal plant recorded in in Chinese Pharmacopeia. Here we report on the complete chloroplast genome sequence of Euodia ruticarpa. The chloroplast genome is 158,762 bp in size and includes two inverted repeat regions of 54,230 bp, which is separated by a large single-copy region of 86,267 bp and a small single copy region of 18,265 bp. A total of 131 genes were predicted, including 37 tRNA, 8 rRNA, and 86 protein-coding genes. Phylogenetic analysis placed Euodia ruticarpa under the family Rutaceae.

Keywords: Euodia ruticarpa; chloroplast; genome sequence; high-throughput sequencing.

Grants and funding

This work was supported by Program of Survey and Monitoring of Chinese Medicines for National Drugs [[2017] 66], China Hunan Provincial Science & Technology Department [2019GK5081, 2019XF5064], Changsha Science & Technology program [kq1905027] and key project at central government level for the ability establishment of sustainable use for valuable Chinese medicine resources [2060302].